We want to help improve the lives and futures of children on the autism spectrum

Wolfgang Storf, CEO, Neurotech International Ltd.


We want to improve people’s lives by developing and commercialising innovative, high quality medical solutions for the diagnosis and treatment of brain-related disorders.

The AAT Research group of companies is a fully owned subsidiary of Neurotech International Limited, an Australian public company (ASX:NTI). We research, design, develop and manufacture quality medical solutions. With regulatory and quality systems in place and various international accreditations to our name, our purpose is to improve people’s lives though innovation in the field of neuroscience and medical technology. Our mission is to be a global leader in the field of neurophysiology by offering solutions suitable for home-use and clinics at affordable prices.

For further information on Neurotech, please click here.

Our Mission

To improve the lives of people with neurological conditions.

Our Vision

To become a global leader in home-use and clinical neurotechnology solutions, which are accessible and affordable.

Our commitment to Quality

Commitment to the effectiveness of its QMS per regulatory requirements, whilst continuously improving the research and efficiency of its present and future medical devices.

Our Company Culture


To be team players, show care and compassion and to always communicate freely, clearly and respectfully.

Results driven

To strive to achieve more than what is expected and to deliver what we promise without compromising quality or integrity.

Customer- and quality-focused

To give highest priority to customer satisfaction and listen to customers and their needs.


To respect oneself and others, pushing for honesty, integrity and trust among colleagues.